SOX10 by immunohistochemistry (IHC) is used primarily for the diagnosis of melanoma.
SOX10 expression has been previously documented in benign breast myoepithelial cells.
However there is limited literature on its expression in triple-negative breast carcinoma
(TNBC). The aim was to study the clinical, pathologic and molecular profiles of SOX10+
tumors in TNBC. Tissue microarrays of TNBC were evaluated for SOX10 expression in 48 …